Table 4. Diagnoses of cases with skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine by general practitioners and dermatologists, Germany, 2020 (n = 72).

Diagnoses of cases	VZV-positive casesa	VZV-negative casesc	Total
	n	n	n	%
Number of cases	27	45	72
By general practitioners
HZ or varicella	26b	26	52b	72.2
No HZ or varicella	1	19	20	27.8
By two dermatologists
HZ	25b	0	25b	34.7
HSV	0	9	9	12.5
Exanthema	0	2	2	2.8
Eczema	0	2	2	2.8
Folliculitis	0	1	1	1.4
Discordant diagnoses	2	2	4	5.5
Discordant differential diagnoses	0	29	29	40.3
By third dermatologist
Number of responses	2	2	4
HZ	1	0	1
Non-assessable	1	2	3

HSV: herpes-simplex virus; HZ: herpes zoster; VZV: varicella-zoster virus.

^a All VZV-positive samples were genotyped to wild-type VZV strains.

^b One patient sample was PCR positive for VZV and HSV-1.

^c Two VZV-negative samples were PCR positive for HSV-1 and five for HSV-2.

Percentages not included where n < 50.